Vanda Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
Vanda Pharmaceuticals Inc. has filed 1,327 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 726-750 of 954 matching filings.

Per page
25
Current page
30
SC 13G/A File 005-82196

SC 13G/A filing

Filing date
06 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

8-K

Filing date
31 Jan 2014
Reporting date
31 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82196

SC 13G/A filing

Filing date
31 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-193614

S-8

Filing date
28 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

8-K

Filing date
28 Jan 2014
Reporting date
24 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82196

AMENDMENT NO. 2

Filing date
16 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-82196

SC 13G filing

Filing date
10 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
05 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
04 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2013
Reporting date
19 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2013
Reporting date
19 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Nov 2013
Reporting date
19 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
15 Nov 2013
Reporting date
14 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
07 Nov 2013
Reporting date
07 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-82196

SC 13G filing

Filing date
11 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-191434

EFFECT filing

Filing date
04 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-191434

FORM S-3

Filing date
27 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82196

SCHEDULE 13G/A

Filing date
12 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171963

RULE 424(B)(5)

Filing date
07 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
07 Aug 2013
Reporting date
07 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34186

FORM 8-K

Filing date
06 Aug 2013
Reporting date
06 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .